In the Jun 2026 quarter (standalone), Rajshree Sugars & Chemicals reported sales of ₹153 Cr, up 8.6% from Jun 2025, and net profit of −₹23.02 Cr. For the year to Mar 2026, sales were ₹545 Cr and net profit ₹1.01 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 213 | 137 | 186 | 240 | 146 | 80.96 | 175 | 141 | 117 | 98.02 | 189 | 153 |
| Expenses | 184 | 155 | 158 | 223 | 135 | 97.65 | 146 | 146 | 115 | 109 | 137 | 166 |
| Operating Profit | 27.94 | −17.97 | 27.94 | 15.96 | 10.98 | −16.96 | 28.93 | −4.99 | 1.99 | −10.97 | 51.91 | −13.96 |
| OPM % | 13.0% | −13.0% | 15.0% | 7.0% | 7.0% | −21.0% | 17.0% | −3.7% | 1.4% | −11.0% | 27.0% | −9.0% |
| Other Income | 1.01 | 0.00 | 11.04 | 0.00 | 4.01 | 6.03 | 1.01 | 0.00 | 1.01 | 1.01 | 1.01 | 0.00 |
| Interest | 5.01 | 4.02 | 10.04 | 5.01 | −2.01 | 4.01 | 9.03 | 3.01 | 3.01 | 4.01 | 4.01 | 4.01 |
| Depreciation | 6.01 | 6.01 | 6.02 | 6.01 | 6.01 | 6.01 | 6.02 | 6.01 | 6.01 | 6.01 | 6.01 | 6.02 |
| Profit before tax | 16.99 | −28.02 | 23.01 | 5.99 | 11.01 | −19.99 | 15.01 | −13.99 | −7.01 | −19.01 | 43.01 | −23.02 |
| Tax % | 0.0% | 0.0% | 32.1% | 0.0% | 0.0% | 0.0% | 20.1% | 0.0% | 0.0% | −52.9% | 26.1% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −2.01 | 0.00 | 0.00 |
| Net Profit | 17.02 | −28.01 | 16.01 | 6.01 | 11.01 | −20.01 | 12.01 | −14.02 | −7.01 | −8.99 | 32.01 | −23.02 |
| EPS (Rs) | 5.17 | −8.35 | 4.76 | 1.78 | 3.23 | −6.16 | 3.57 | −4.26 | −2.16 | −2.76 | 9.54 | −7.03 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 570 | 667 | 552 | 399 | 327 | 364 | 468 | 767 | 764 | 642 | 545 | 557 |
| Expenses | 531 | 525 | 517 | 384 | 318 | 335 | 435 | 713 | 706 | 601 | 506 | 526 |
| Operating Profit | 37.93 | 141 | 33.92 | 13.97 | 8.98 | 27.96 | 31.91 | 51.91 | 55.88 | 38.90 | 37.93 | 28.97 |
| OPM % | 7.0% | 21.0% | 6.0% | 3.6% | 2.7% | 8.0% | 7.0% | 7.0% | 7.0% | 6.0% | 7.0% | 5.2% |
| Other Income | 32.12 | 3.01 | 24.11 | 3.01 | 3.01 | 10.04 | 12.05 | 7.03 | 13.05 | 12.04 | 2.01 | 3.03 |
| Interest | 65.26 | 72.29 | 60.19 | 58.18 | 58.20 | 29.09 | 22.06 | 14.05 | 24.09 | 16.05 | 14.04 | 15.04 |
| Depreciation | 26.04 | 26.05 | 25.06 | 25.05 | 25.06 | 24.06 | 24.07 | 24.06 | 24.06 | 23.06 | 23.05 | 24.05 |
| Profit before tax | −21.01 | 46.02 | −27.02 | −65.01 | −69.99 | −15.99 | −3.01 | 21.01 | 21.01 | 11.01 | 2.01 | −6.03 |
| Tax % | −30.9% | 34.1% | −53.9% | −35.9% | −29.9% | 6.1% | 22.1% | 143.1% | 35.1% | 27.1% | 41.1% | — |
| Exceptional items | 28.04 | 0.00 | 22.01 | 0.00 | 0.00 | 4.01 | 2.01 | 1.01 | 0.00 | 0.00 | 0.00 | −2.01 |
| Net Profit | −14.01 | 30.02 | −13.01 | −42.01 | −49.04 | −17.01 | −3.01 | −9.01 | 14.01 | 8.01 | 1.01 | −7.01 |
| EPS (Rs) | −5.73 | 10.65 | −4.46 | −14.81 | −17.49 | −5.94 | −0.95 | −2.70 | 4.14 | 2.43 | 0.33 | −2.41 |
| Dividend payout % | 0.0% | 9.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23.94 | 24.94 | 27.91 | 27.94 | 27.94 | 27.95 | 27.93 | 32.92 | 32.94 | 32.94 | 32.92 | 32.92 |
| Reserves | 23.99 | 12.00 | 116 | 103 | 62.11 | 11.01 | 2.00 | 228 | 218 | 232 | 231 | 230 |
| Borrowings | 675 | 691 | 614 | 458 | 403 | 358 | 432 | 427 | 401 | 393 | 299 | 332 |
| Other Liabilities | 144 | 144 | 328 | 169 | 249 | 282 | 212 | 248 | 169 | 147 | 122 | 110 |
| Total Liabilities | 866 | 872 | 1,086 | 759 | 742 | 679 | 675 | 937 | 822 | 805 | 687 | 705 |
| Fixed Assets | 513 | 489 | 551 | 528 | 505 | 483 | 427 | 612 | 589 | 569 | 524 | 496 |
| CWIP | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.99 | 0.99 | 0.99 |
| Investments | 67.02 | 67.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 284 | 314 | 535 | 229 | 235 | 195 | 247 | 324 | 231 | 235 | 161 | 207 |
| Inventories | 195 | 218 | 312 | 140 | 114 | 72.77 | 122 | 178 | 149 | 171 | 117 | 164 |
| Trade receivables | 34.09 | 54.13 | 57.10 | 48.08 | 63.14 | 43.07 | 31.06 | 30.05 | 40.06 | 31.05 | 24.06 | 23.06 |
| Cash & equivalents | 4.02 | 3.01 | 57.21 | 3.01 | 4.02 | 5.02 | 2.01 | 3.01 | 2.01 | 5.02 | 1.01 | 7.03 |
| Total Assets | 866 | 872 | 1,086 | 759 | 742 | 679 | 675 | 937 | 822 | 805 | 687 | 705 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 14.99 | 34.94 | 132 | 148 | 70.88 | 45.92 | 17.99 | 23.97 | 15.98 | 38.93 | 82.87 | −19.98 |
| Cash from investing activity | −5.98 | 0.99 | 72.73 | 13.95 | −1.99 | −7.97 | 18.92 | 7.97 | 46.80 | −2.99 | 17.93 | 8.97 |
| Cash from financing activity | −93.16 | −38.10 | −150 | −216 | −69.13 | −36.09 | −40.11 | −31.07 | −63.12 | −32.04 | −104 | 17.04 |
| Net cash flow | −84.08 | −2.01 | 55.03 | −54.07 | 0.00 | 3.01 | −3.01 | 0.00 | −1.01 | 3.01 | −4.01 | 6.01 |
| Capex | 2.02 | 1.63 | 2.73 | 5.61 | 1.79 | 7.65 | 1.35 | 0.63 | 4.04 | 4.19 | 4.53 | 3.93 |
| Free cash flow | 12.99 | 32.99 | 129 | 143 | 68.94 | 37.96 | 36.96 | 30.98 | 61.99 | 34.97 | 99.95 | −10.99 |
| CFO / OP % | 178.0% | 90.9% | 93.0% | 465.9% | 493.9% | 522.0% | 66.0% | 68.9% | 31.0% | 67.9% | 214.9% | −54.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 23 | 36 | 32 | 32 | 58 | 49 | 32 | 25 | 20 | 16 | 15 | 17 |
| Inventory days | 161 | 193 | 286 | 130 | 145 | 110 | 176 | 197 | 97 | 114 | 91 | 160 |
| Days payable | 93 | 92 | 157 | 118 | 218 | 222 | 208 | 180 | 87 | 78 | 70 | 63 |
| Cash conversion cycle | 89 | 135 | 159 | 42 | −17 | −64 | −1 | 40 | 27 | 50 | 34 | 112 |
| Working capital days | −40 | −65 | −64 | −88 | −226 | −413 | −62 | −15 | 8 | −5 | 4 | 0 |
| ROCE % | −2.0% | 2.0% | 15.9% | 2.0% | −1.0% | −3.0% | 2.0% | 3.0% | 5.0% | 6.9% | 4.0% | 3.0% |
For the Jun 2026 quarter, Rajshree Sugars & Chemicals reported sales of ₹153 Cr, up 8.6% year on year and net profit of −₹23.02 Cr. The operating margin was −9.0%.
Rajshree Sugars & Chemicals' sales for the year to Mar 2026 were ₹545 Cr; over the last twelve months they were ₹557 Cr.
Net profit for the year to Mar 2026 was ₹1.01 Cr, and −₹7.01 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.41.
Rajshree Sugars & Chemicals reported borrowings of ₹332 Cr at Mar 2026, against cash and equivalents of ₹7.03 Cr.
Cash from operations was −₹19.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹10.99 Cr.